Bibliometric analysis of ferroptosis in atherosclerosis from 2015 to 2024

Ke-Qian Chen1, Wei Li1, Shu-Zhi Wang2

  • 1Department of Clinical Pharmacy, Xiangtan Central Hospital (The Affiliated Hospital of Hunan University), Xiangtan 411100, China.

Insights

This bibliometric analysis reveals research trends in ferroptosis and atherosclerosis. It highlights key authors, institutions, and countries contributing to this field, offering insights for future studies on ferroptosis inhibition in atherosclerosis.

Area of Science:

  • Biomedical research
  • Cardiovascular science
  • Cellular biology

Background:

  • Ferroptosis is increasingly recognized for its role in disease.
  • Inhibiting ferroptosis shows promise for managing atherosclerosis.
  • A bibliometric analysis of ferroptosis in atherosclerosis research was lacking.

Purpose of the Study:

  • To analyze research trends in ferroptosis and atherosclerosis.
  • To provide a valuable reference for future research in this domain.
  • To deepen the understanding of ferroptosis's role in atherosclerosis.

Main Methods:

  • Bibliometric analysis using Web of Science core database (SCI EXPANDED).
  • Searched for 'ferroptosis' and 'atherosclerosis' from January 2015 to December 2024.
  • Utilized VOSviewer and CiteSpace for visual and cluster analysis of authors, institutions, countries, journals, and keywords.

Main Results:

  • Analyzed 274 articles involving 1774 authors, 363 institutions, 32 countries, 153 journals, and 1212 keywords.
  • China led in publications, with Harbin Medical University and Sun Yat-Sen University as key institutions.
  • Ferroptosis was the most frequent and co-occurring keyword, indicating its central role.

Conclusions:

  • This study provides a comprehensive overview of the research landscape concerning ferroptosis and atherosclerosis.
  • Identified leading contributors and collaboration patterns to guide future research directions.
  • Highlights the significance of ferroptosis as a research focus in atherosclerosis studies.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
835
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
444
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
348